Arcutis Biotherapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ARQT Nasdaq 2830 www.arcutis.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arcutis Biotherapeutics, Inc.

Arcutis to Report Fourth Quarter and Full Year 2025 Financial Results and Present at Upcoming Investor Conference - Jan 22nd, 2026 2:00 pm
Nationwide Survey Underscores Concerns with Use of Topical Steroids and Need for Long-Term Treatment Strategies Facing the 46 Million Americans with Chronic Inflammatory Skin Conditions - Jan 21st, 2026 6:00 am
Strength Seen in ANI (ANIP): Can Its 10.6% Jump Turn into More Strength? - Jan 13th, 2026 2:21 am
Arcutis Highlights 2026 Strategic Priorities and Anticipated Milestones - Jan 12th, 2026 6:00 am
Is Suvretta’s Stake Cut and FDA’s Pediatric Review Acceptance Altering The Investment Case For Arcutis Biotherapeutics (ARQT)? - Dec 24th, 2025 4:18 pm
Arcutis Stock Is Up 100% in a Year but Here’s Why One Fund Still Sold 1 Million Shares - Dec 23rd, 2025 10:38 am
Are Medical Stocks Lagging Compass Therapeutics, Inc. (CMPX) This Year? - Dec 19th, 2025 7:40 am
Zacks Industry Outlook Arcutis, Amicus and ANI - Dec 18th, 2025 1:43 am
5 Biotech Stocks to Watch for Potential Upside - Dec 17th, 2025 12:19 pm
Assessing Arcutis Biotherapeutics After 99% YTD Surge and Mixed Valuation Signals - Dec 14th, 2025 10:06 am
This Biotech Stock Could Cure Your Portfolio's Pain - Dec 14th, 2025 7:35 am
What Makes Arcutis Biotherapeutics, Inc. (ARQT) a Strong Momentum Stock: Buy Now? - Dec 10th, 2025 10:00 am
Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri - Dec 8th, 2025 2:00 pm
PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know - Dec 8th, 2025 8:39 am
Incyte's Rare Blood Cancer Therapy Gets FDA's Breakthrough Status - Dec 8th, 2025 8:30 am
ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study - Dec 5th, 2025 8:37 am
CAPR Stock Skyrockets 282% in a Week: Here's What You Need to Know - Dec 5th, 2025 8:34 am
Assessing Arcutis Biotherapeutics (ARQT) Valuation After Its Strong 1-Year Share Price Surge - Dec 3rd, 2025 4:15 pm
PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain - Dec 3rd, 2025 8:23 am
AZN's Baxdrostat Gets FDA Priority Tag for Uncontrolled Hypertension - Dec 3rd, 2025 8:01 am